Allergy/Asthma

Oral immunotherapy was associated with an increase in both desensitization and remission of peanut allergy among children aged younger than 4 years, with younger children seeing greater success, according to data published in The Lancet.

Oral immunotherapy appeared effective and well-tolerated by children with hazelnut allergy, according to a retrospective study published in Annals of Allergy, Asthma & Immunology.

Researchers found that sesame allergy spontaneously resolved in approximately one-third of patients who had a mild first reaction at a young age, according to a study published in Annals of Allergy, Asthma & Immunology.

IV magnesium for children with moderate-to-severe asthma exacerbations was associated with increased exacerbation severity and risk for hospitalization without any acceleration in resolution, according to observational study results.

Laxative exposure early in life was associated with later allergic disease development, including rhinitis, atopic dermatitis and asthma, according to a cohort study published in Annals of Allergy, Asthma & Immunology.

Combustion-related nitrogen dioxide pollution appeared to significantly contribute to pediatric asthma incidence globally, particularly in urban areas, according to data published in The Lancet Planetary Health.

As families and health care providers struggle to manage food allergies, 2021 saw significant advances in research and treatment. Here are our top 10 stories about developments and improvements benefitting these patients.

Most patients with severe cow’s milk allergy can be safely desensitized to substantial levels of baked milk through baked milk oral immunotherapy, according to a study published in The Journal of Allergy and Clinical Immunology.

The FDA issued an FDA Modernization Act health claim on Dec. 8 acknowledging the safety of the early introduction of peanuts among infants to reduce the risk for developing peanut allergy.

Infants who ate a more diverse diet during their first year had lower risk for allergic diseases during their second year, according to a study published in Pediatric Allergy and Immunology.